Pulmonary Disease, Chronic Obstructive Clinical Trial
— SMTOfficial title:
the Relationship Between Spot Marching Exercise Test and Six Minute Walk Test in Patient With Chronic Obstructive Pulmonary Disease
the aim of this study to assess the relationship and compare physiological response between spot marching exercise test and 6 minute walk test in patient with chronic obstructive pulmonary disease
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | December 2017 |
| Est. primary completion date | June 2017 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 35 Years to 75 Years |
| Eligibility |
Inclusion Criteria: - mild to very severe COPD patients Exclusion Criteria: - Exacerbate within a month prior, which was a cause of admission to the hospital emergency room or been admitted to hospital. - Are changed medicines within a month ago. - Have been used home oxygen therapy. - Have musculoskeletal or neuromuscular problem affecting balance and walking. - Using walking aid device. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| Thailand | Khonkaen univercity | Khonkaen | |
| Thailand | Khon Kaen Hospital | Muang Khon Kaen | Khon Kaen |
| Lead Sponsor | Collaborator |
|---|---|
| Khon Kaen University |
Thailand,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | number of step of Spot Marching Test | up to 6 min | No | |
| Secondary | Heart rate | every minute at pre-exercise for 5 min, during exercise test for 6 min and recovery phase for 10 min | Yes | |
| Secondary | Electrocardiogram (lead II) | every minute at pre-exercise for 5 min, during exercise test for 6 min and recovery phase for 10 min | Yes | |
| Secondary | Respiratory rate | every minute at pre-exercise for 5 min, during exercise test for 6 min and recovery phase for 10 min | No | |
| Secondary | Blood pressure | include , systolic blood pressure, diastolic blood pressure, mean arterial pressure | up to 2 minute in recovery phase | Yes |
| Secondary | peripheral oxygen saturation (SpO2) | every minute at pre-exercise for 5 min, during exercise test for 6 min and recovery phase for 10 min | Yes | |
| Secondary | partial pressure of end tidal carbondioxide | every minute at pre-exercise for 5 min, during exercise test for 6 min and recovery phase for 10 min | Yes | |
| Secondary | number of step of 6 minute walk test | up to 6 min | No | |
| Secondary | distance of 6 minute walk test | up to 6 min | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
| Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
| Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
| Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
| Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
| Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
| Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
| Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
| Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
| Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
| Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
| Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
| Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
| Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|